SHENZHEN MINDRAY BIO-MEDICA CNY 1.0's ticker is and the CUSIP is Y774E3101. A total of 1 filers reported holding SHENZHEN MINDRAY BIO-MEDICA CNY 1.0 in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,265,000 | -9.9% | 30,000 | 0.0% | 0.24% | -4.0% |
| Q2 2022 | $1,404,000 | -3.4% | 30,000 | 0.0% | 0.25% | +24.4% |
| Q1 2022 | $1,453,000 | -18.9% | 30,000 | 0.0% | 0.20% | -4.7% |
| Q4 2021 | $1,792,000 | -14.1% | 30,000 | -14.3% | 0.21% | -22.1% |
| Q3 2021 | $2,087,000 | +117.8% | 35,000 | +171.3% | 0.27% | +99.3% |
| Q2 2021 | $958,000 | +22.0% | 12,900 | 0.0% | 0.14% | +4.6% |
| Q1 2021 | $785,000 | +10.6% | 12,900 | +18.3% | 0.13% | +3.2% |
| Q4 2020 | $710,000 | +256.8% | 10,900 | +179.5% | 0.13% | +186.4% |
| Q3 2020 | $199,000 | – | 3,900 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stanley-Laman Group, Ltd. | 30,000 | $1,453,000 | 0.20% |